Literature DB >> 11857336

Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.

Kazuyuki Tsunoda1, Takayuki Ota, Harumi Suzuki, Manabu Ohyama, Tetsuo Nagai, Takeji Nishikawa, Masayuki Amagai, Shigeo Koyasu.   

Abstract

Mechanisms of tolerance break against desmoglein 3 (Dsg3) in patients with pemphigus vulgaris (PV) producing pathogenic anti-Dsg3 IgG autoantibodies are unclear. In this study, using a novel PV mouse model involving Dsg3 knockout mice, we investigated the mechanisms leading to production of autoantibodies against Dsg3. Adoptive transfer of Dsg3(-/-) splenocytes immunized with recombinant mouse Dsg3 to Rag2(-/-) recipient mice expressing Dsg3 resulted in the stable production of anti-Dsg3 IgG and development of PV phenotypes including oral erosions with suprabasilar acantholysis. When purified T and B cells from Dsg3(-/-), Dsg3(+/-) or Dsg3(+/+) mice were mixed with various combinations and transferred to Rag2(-/-) mice, pathogenic anti-Dsg3 IgG production was observed only with a combination of Dsg3(-/-) T and Dsg3(-/-) B cells but not with the other combinations. These results suggest that loss of tolerance against Dsg3 in both B and T cells is important for the development of autoimmune state of PV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857336     DOI: 10.1002/1521-4141(200203)32:3<627::AID-IMMU627>3.0.CO;2-1

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

Review 1.  T cell control in autoimmune bullous skin disorders.

Authors:  Michael Hertl; Rüdiger Eming; Christian Veldman
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 2.  Immunotherapy for Pemphigus: Present and Future.

Authors:  Huijie Yuan; Meng Pan; Hongxiang Chen; Xuming Mao
Journal:  Front Med (Lausanne)       Date:  2022-06-15

Review 3.  Effects of acute and chronic inflammation on B-cell development and differentiation.

Authors:  Derek Cain; Motonari Kondo; Huaiyong Chen; Garnett Kelsoe
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

Review 4.  Immune response in pemphigus and beyond: progresses and emerging concepts.

Authors:  Giovanni Di Zenzo; Kyle T Amber; Beyza S Sayar; Eliane J Müller; Luca Borradori
Journal:  Semin Immunopathol       Date:  2015-11-23       Impact factor: 9.623

Review 5.  Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity.

Authors:  Donna A Culton; Ye Qian; Ning Li; David Rubenstein; Valeria Aoki; Gunter Hans Filhio; Evandro A Rivitti; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-05       Impact factor: 7.094

Review 6.  [B-cell-depleting antibodies in skin diseases].

Authors:  A Nagel; M Hertl; R Eming
Journal:  Hautarzt       Date:  2008-10       Impact factor: 0.751

Review 7.  A reciprocal HLA-Disease Association in Rheumatoid Arthritis and Pemphigus Vulgaris.

Authors:  Vincent Van Drongelen; Joseph Holoshitz
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

Review 8.  Autoimmune and infectious skin diseases that target desmogleins.

Authors:  Masayuki Amagai
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 9.  Pemphigus autoimmunity: hypotheses and realities.

Authors:  Sergei A Grando
Journal:  Autoimmunity       Date:  2011-09-23       Impact factor: 2.815

10.  Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis.

Authors:  L Yan; J-M Wang; K Zeng
Journal:  Br J Dermatol       Date:  2012-08-20       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.